TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains
Clinical trial NCT00964327 · COMPLETED
Trial details
- NCT number
- NCT00964327
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2003-10-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.